ELOCON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Elocon, and when can generic versions of Elocon launch?
Elocon is a drug marketed by Organon and is included in three NDAs.
The generic ingredient in ELOCON is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Elocon
A generic version of ELOCON was approved as mometasone furoate by PADAGIS US on March 18th, 2002.
Summary for ELOCON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,548 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ELOCON |
| What excipients (inactive ingredients) are in ELOCON? | ELOCON excipients list |
| DailyMed Link: | ELOCON at DailyMed |
Recent Clinical Trials for ELOCON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| LEO Pharma | Phase 1 |
| University of Oulu | Phase 4 |
| Schering-Plough | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ELOCON
Paragraph IV (Patent) Challenges for ELOCON
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| ELOCON | Topical Solution (Lotion) | mometasone furoate | 0.1% | 019796 | 1 | 2004-06-10 |
US Patents and Regulatory Information for ELOCON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Organon | ELOCON | mometasone furoate | OINTMENT;TOPICAL | 019543-001 | Apr 30, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Organon | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-002 | Apr 19, 2013 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ELOCON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
| Organon | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
| Organon | ELOCON | mometasone furoate | OINTMENT;TOPICAL | 019543-001 | Apr 30, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ELOCON
See the table below for patents covering ELOCON around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Denmark | 162770 | ⤷ Try a Trial | |
| Austria | 62815 | ⤷ Try a Trial | |
| Australia | 8071287 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ELOCON
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3043773 | 2022C/520 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE OF EEN ZOUT HIERVAN EN OLOPATADINE OF EEN ZOUT HIERVAN; AUTHORISATION NUMBER AND DATE: BE595626 20220203 |
| 0057401 | 94C0002 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONI FUROAS; NAT. REG.: 304 S 131 F 7 19930813; FIRST REG.: GR 10681/89 19900622 |
| 3043773 | 132021000000191 | Italy | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE O UN SUO SALE E OLOPATADINA O UN SUO SALE(RYALTRIS); AUTHORISATION NUMBER(S) AND DATE(S): 048499014, 048499026, 048499038, 20210726;140638, 20210426 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
